Dr. Scott Daniel Richard, MD

Dr. Richard practices at Summit Medical Group Ambulatory Surgery Center - Berkeley Heights in Berkeley Heights, New Jersey.

Dr. Richard's NPI, 1518002567, was assigned on February 20, 2007. Dr. Richard graduated from Albany Medical College in 2001. Dr. Richard holds New Jersey license 25MA11732100.

Dr. Richard's primary practice is Summit Medical Group Ambulatory Surgery Center - Berkeley Heights, at 1 Diamond Hill Road, Suite 1b-142, Berkeley Heights, NJ 07922. The practice phone is (908) 273-4300.

Dr. Richard's primary practice is Summit Medical Group Ambulatory Surgery Center - Berkeley Heights in Berkeley Heights, New Jersey. Dr. Richard is also affiliated with Cooperman Barnabas Medical Center. The medical group on file is Summit Health. Dmand AI also links Dr. Richard to 2 more medical groups and 1 group practice or clinic, each named with a free account. Dr. Richard's employer is on file too: a surgery center (asc).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Richard practices, 3 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Richard's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dmand AI has Dr. Richard's licenses on file in 2 states: New Jersey and Pennsylvania.

CMS data shows 666 Medicare services from Dr. Richard across 11 procedure codes in 2024, for 246 Medicare patients. Medicare paid $97,036 for them.

CMS counts 246 Medicare patients who saw Dr. Richard in 2024. The largest group is 65 to 74, with 138 patients. 75% of them have high cholesterol, and 73% have high blood pressure. Their average risk score is 1.25, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Richard's median patient age at 61, with 96% women.

In 2024, Dr. Richard wrote 60 Medicare Part D claims for 39 patients. 88% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $27 in total drug cost. In 2023, CMS named 11 claims across 1 drug.

Dr. Richard accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Richard as offering telehealth. CMS counts 40 procedures of removal of the uterus by Dr. Richard, more than 98% of the clinicians it reports for that procedure.

Dmand AI links 47 papers to Dr. Richard, published from 2011 to 2022. 2015 was the busiest year, with 5. The most frequent topics are Ovarian Neoplasms, Peritoneal Neoplasms and Uterine Cervical Neoplasms. Dr. Richard has published most often in Gynecol Oncol. Dr. Richard's most frequent co-authors are Thomas Carl Krivak, MD, Sushil Beriwal, MD and Paniti Sukumvanich.

Dmand AI links Dr. Richard to 9 clinical trials, 3 of them phase 3 studies. 5 are still active or recruiting. Conditions studied include Fallopian Tube Diseases, Fallopian Tube Neoplasms and Carcinosarcoma. National Cancer Institute (NCI) sponsors the most, 6. Open Payments lists research payments to Dr. Richard that name 1 trial.

CMS Open Payments shows 194 general payments to Dr. Richard from 14 drug and device companies from 2016 to 2024. Speaker and faculty fees make up the largest share, 75% of the total. Clovis Oncology, Inc. paid the most, $149,622. It also lists 6 research payments totaling $15,601 in 2017, naming 1 clinical trial.

Dr. Richard graduated from Albany Medical College in 2001.